Role of Home-Based Transcutaneous Electrical Acustimulation for Treatment of Pain in Subjects With Chronic Pancreatitis
Key facts
- Who runs it
- University of Michigan
- Where
- Ann Arbor, United StatesSee the site
- Trial code
- Status
- Completed
- People taking part
- 42 people enrolled
- Started
- 13 Jan 2025
- Ended
- 16 Feb 2026
- Type of study
- Interventional, 2 groups
- Treatments tested
- TEA
- Record updated
- 6 March 2026
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 21 criteriaShow less
Who can take part
- Diagnosis of definite or suspected Chronic Pancreatitis (CP). Definite CP features include presence of pancreatic calcifications or Cambridge grade 3-4 on imaging. Suspected CP features include presence of Rosemont criteria suggestive of CP on endoscopic ultrasound or 2 documented attacks of acute pancreatitis separated by at least 1 month without other definite or suspected CP features
- Abdominal pain that is present for at least 3 months prior to enrollment and having experienced moderate intensity abdominal pain (rated as 4 or higher on a 0-10 Numeric Rating Scale) at least once in the last month
Who cannot take part
- Currently receiving acupuncture therapy
- Had during the past month or plan to have within the next 3 months at least one of the following procedures: endoscopic retrograde cholangiopancreatography, pancreatic pseudocyst drainage, celiac plexus block or neurolysis, extracorporeal shock wave lithotripsy, or surgical pancreatic resection or drainage procedure
- Undergoing treatment for cancer or has a suspected or confirmed diagnosis of pancreatic cancer
- Substantial cognitive impairment or mental illness that would prevent providing informed consent and completion of questionnaires
- Any other condition, which in the opinion of the investigator would impede compliance or hinder the completion of the study
- History of total pancreatectomy with or without islet autotransplantation
- Known allergy to adhesive Electrocardiogram (ECG) electrodes
- History of vagal nerve surgery
- History of bilateral below the knee amputation
- History of lower extremity paralysis
- Breastfeeding mother
- Pregnant or intending to become pregnant within the next 3 months
- Incarcerated individuals
- Unwillingness or inability to consent
- Unable to read and speak English precluding completion of questionnaires
- Familiarity with acupoints that limit blinding
- Participation in another clinical trial
- Presence of obstructed pancreatic duct that has not yet undergone an attempt for ductal decompression
- Presence of an implantable electrical stimulation device
Where in United States
- University of MichiganAnn Arbor, United States
About the trial
What the trial wants to find out
Transcutaneous Electrical Acustimulation (TEA) is a noninvasive acupuncture method that can be self-administered at home without needles. TEA transmits a weak electrical current using electrodes placed at acupoints and has shown to safely reduce pain in other gastrointestinal conditions. This study will help elucidate if TEA is effective in treating abdominal pain in patients with painful chronic pancreatitis (CP).
The 2 groups in the trial
- Active TEA first followed by sham TEATreatment being tested
Subjects will undergo active TEA for 4 weeks (week 1-4) followed by a 2-week washout period and then sham TEA for 4 weeks (week 7-10). Subjects will have two instruction visits, one before starting active TEA and one before starting sham TEA.
Treatment: TEA
- Sham TEA first followed by active TEATreatment being tested
Subjects will undergo sham TEA for 4 weeks (week 1-4) followed by a 2-week washout period and then active TEA for 4 weeks (week 7-10). Subjects will have two instruction visits, one before starting active TEA and one before starting sham TEA.
Treatment: TEA
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Role of Home-Based Transcutaneous Electrical Acustimulation for Treatment of Pain in Patients With Chronic Pancreatitis (TEA-CuP): A Double-Blind, Sham-Controlled Crossover Trial
- Record updated
- 6 March 2026